HFS
RIGL icon

Hughes Financial Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Hughes Financial Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.6K Buy
1,601
+1
+0.1% +$31 0.01% 159
2026
Q1 		$43.3K Buy
1,600
+599
+60% +$20.1K 0.01% 177
2025
Q4 		$42.9K Buy
+1,001
New +$37.7K 0.01% 170

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's RIGL Position: Q2 2026 in Review

Hughes Financial Services increased its Rigel Pharmaceuticals (RIGL) stake by 0.06% in Q2 2026, buying an estimated $31 and bringing the position to 1,601 shares worth $62.6K. The position accounts for 0.01% of the portfolio, ranked #159.

Hughes Financial Services first reported a position in RIGL in Q4 2025 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Hughes Financial Services held 1,601 shares of Rigel Pharmaceuticals worth $62.6K as of Q2 2026.
  • Hughes Financial Services bought 1 Rigel Pharmaceuticals share in Q2 2026, an estimated $31.
  • Rigel Pharmaceuticals made up 0.01% of Hughes Financial Services's portfolio in Q2 2026, its #159 holding.
  • Hughes Financial Services first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.